JPH0755896B2 - Cosmetics - Google Patents
CosmeticsInfo
- Publication number
- JPH0755896B2 JPH0755896B2 JP61013721A JP1372186A JPH0755896B2 JP H0755896 B2 JPH0755896 B2 JP H0755896B2 JP 61013721 A JP61013721 A JP 61013721A JP 1372186 A JP1372186 A JP 1372186A JP H0755896 B2 JPH0755896 B2 JP H0755896B2
- Authority
- JP
- Japan
- Prior art keywords
- skin
- complex protein
- water
- effect
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002537 cosmetic Substances 0.000 title claims description 13
- 102000004169 proteins and genes Human genes 0.000 claims description 38
- 108090000623 proteins and genes Proteins 0.000 claims description 38
- 241000283690 Bos taurus Species 0.000 claims description 12
- 210000003681 parotid gland Anatomy 0.000 claims description 12
- 239000002244 precipitate Substances 0.000 claims description 10
- 239000000284 extract Substances 0.000 claims description 7
- 239000002131 composite material Substances 0.000 claims description 2
- 210000003491 skin Anatomy 0.000 description 32
- 230000000694 effects Effects 0.000 description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 238000000034 method Methods 0.000 description 10
- 239000000203 mixture Substances 0.000 description 9
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 8
- 206010016807 Fluid retention Diseases 0.000 description 8
- 239000006071 cream Substances 0.000 description 8
- 230000007423 decrease Effects 0.000 description 7
- 239000006210 lotion Substances 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 210000000434 stratum corneum Anatomy 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 230000032683 aging Effects 0.000 description 6
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- 238000002156 mixing Methods 0.000 description 5
- 229940058015 1,3-butylene glycol Drugs 0.000 description 4
- 235000019437 butane-1,3-diol Nutrition 0.000 description 4
- 210000002615 epidermis Anatomy 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 3
- 239000006286 aqueous extract Substances 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 3
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 3
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 3
- 229960002216 methylparaben Drugs 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 210000004927 skin cell Anatomy 0.000 description 3
- 239000001587 sorbitan monostearate Substances 0.000 description 3
- 235000011076 sorbitan monostearate Nutrition 0.000 description 3
- 229940035048 sorbitan monostearate Drugs 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 206010048222 Xerosis Diseases 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000037336 dry skin Effects 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 210000003079 salivary gland Anatomy 0.000 description 2
- 230000037067 skin hydration Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 102000013563 Acid Phosphatase Human genes 0.000 description 1
- 108010051457 Acid Phosphatase Proteins 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- -1 Carboxyl vinyl Chemical group 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 210000001913 submandibular gland Anatomy 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 230000036572 transepidermal water loss Effects 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Cosmetics (AREA)
Description
【発明の詳細な説明】 <産業上の利用分野> 本発明は、牛の耳下腺から得られる複合蛋白質を配合し
た化粧料に関する。DETAILED DESCRIPTION OF THE INVENTION <Industrial field of application> The present invention relates to cosmetics containing a complex protein obtained from the parotid gland of cattle.
更に詳しくは、本発明は牛の耳下腺中に含まれる複合蛋
白質の働きにより、皮膚に対して優れた保湿効果、保護
効果、美肌効果を付与し得る新規な化粧料を提供せんと
するものである。More specifically, the present invention provides a novel cosmetic composition capable of imparting an excellent moisturizing effect, protective effect, and skin beautiful effect to the skin by the action of the complex protein contained in the parotid gland of cattle. Is.
<従来の技術及び発明が解決しようとする課題> 従来より、皮膚の柔軟性や美肌の維持には皮膚の水分量
が深く関与し、またこの皮膚水分の保持機能に中心的役
割を果しているのが角層であると言われている。<Problems to be Solved by Conventional Techniques and Inventions> Conventionally, the amount of moisture in the skin has been deeply involved in maintaining the flexibility and beautiful skin of the skin, and also has a central role in the function of retaining the skin moisture. Is said to be the stratum corneum.
しかし、この皮膚特に角層の水分保持機能は、環境の変
化例えば冬期に空気が乾燥した時などに、皮膚の分泌物
の減退に伴ない角層のバリヤー機能が減少し、皮膚の水
分貯留能力を超えて経表皮性水分損失(以下T.W.Lと
略)が大きくなったり、または物理的原因(例えば洗浄
等)により、表皮内(特に角層)水分が引き出されたり
した場合には、著しく低下してしまうことが知られてい
る。However, the water-retaining function of the skin, especially the stratum corneum, is that the barrier function of the stratum corneum decreases with the decrease in the secretion of the skin when the environment changes, for example, when the air is dried in the winter, and the skin's water retention ability If the transepidermal water loss (abbreviated as TWL hereafter) becomes greater than the above, or if water in the epidermis (especially the stratum corneum) is drawn out due to a physical cause (for example, washing), it will decrease significantly. It is known to end up.
一方、通常の状態においても、加齢にともなう皮膚蛋白
の変化すなわちコラーゲンの硬化などにより皮膚の水分
保持機能が低下した状態をドライスキンと呼び、老人性
乾皮症などが好適な例として挙げられる。このように表
皮角層の水分は、通常は角層の構成成分と結合し皮膚に
潤いと美肌を与えているが、環境変化や老化等によって
角層の水分含有量が減少し、この水分含有量の減少は、
皮膚がカサカサになったり脆くなって肌あれを生ずるこ
とと密接な関係を持っている。このため、これらの皮膚
状態を改善し、皮膚の水分保持機能を正常に維持するた
めの各種の方法が研究されてきた。On the other hand, even in a normal state, a state in which the water retention function of the skin is deteriorated due to changes in skin proteins with age, that is, hardening of collagen is called dry skin, and senile xerosis and the like are preferable examples. . Thus, the water content of the stratum corneum of the epidermis normally binds to the components of the stratum corneum to give the skin a moisturizing and beautiful skin, but the moisture content of the stratum corneum decreases due to environmental changes and aging, etc. The decrease in volume is
It is closely related to the dryness and brittleness of the skin, which causes rough skin. Therefore, various methods for improving these skin conditions and maintaining the normal water retention function of the skin have been studied.
従来、行なわれてきた方法としては、閉塞剤や保湿剤を
用いてT.W.Lを抑制する方法や皮膚水和効果を高める方
法と、皮膚の老化に対して代謝促進剤を投与してその機
能を回復・正常化する方法とがあった。Conventional methods have been to suppress TWL using occlusive agents and moisturizers, to enhance skin hydration effects, and to administer metabolic stimulants against skin aging to restore its function.・ There was a way to normalize.
前者の例としては、ワセリン軟膏や特開昭54−86630号
に見られる皮脂類似組成物を配合して皮膚表面を被い乾
燥を防止したり、またはエチレングリコール、グリセリ
ン等の多価アルコール、PCA−ソーダ、糖類、ヒアルロ
ン酸および各種天然保湿因子(NMF)成分などの主に保
水性を有する成分を配合して皮膚水分を高める方法があ
るが、これらの場合何れもその効果を高める為には使用
量を多くしなければならず、そのことによりベタベタす
る等の不快な感触になり、逆に使用量を抑えると効果が
弱く持続性がないという欠点があった。更に、これらは
皮膚の細胞に直接作用して、その機能を回復し美肌効果
を発現すると言うことは期待できなかった。Examples of the former include petrolatum ointment and a composition similar to the sebum found in JP-A-54-86630 to prevent the skin from drying by covering the skin surface, or ethylene glycol, polyhydric alcohol such as glycerin, PCA. -There is a method of increasing skin moisture by mixing mainly water-retaining components such as soda, saccharides, hyaluronic acid and various natural moisturizing factor (NMF) components. In any of these cases, in order to enhance the effect, The amount used must be increased, which causes an uncomfortable feeling such as stickiness, and conversely, if the amount used is suppressed, the effect is weak and the durability is not long-lasting. Furthermore, it could not be expected that these act directly on the cells of the skin to restore their function and develop the skin-beautifying effect.
一方、後者の例としては、卵胞ホルモンや副腎皮質ホル
モンなどに代表されるステロイドホルモン類が一般的で
あるが、これらは皮膚細胞の機能回復に対する効果はあ
るものの、多量に使用したり、また長期にわたって使用
したりすると、局所的もしくは全身的な副作用が発現し
たり、表皮の肥厚化を伴なったりするなどの問題点があ
った。On the other hand, as the latter example, steroid hormones typified by estrogen and adrenocortical hormone are generally used, but although they have an effect on the function recovery of skin cells, they are used in large amounts or for a long time. When it is used over a long period of time, there are problems such that local or systemic side effects are caused and the epidermis is thickened.
<課題を解決するための手段> そこで、本発明者は、これら前述の従来法における問題
点を解決し、安全で、しかも優れた保水能をもち、且つ
皮膚細胞を賦活して美肌効果を与える物質を見出すべく
鋭意研究したところ、牛の耳下腺中に含まれる特定の複
合蛋白質に上記効果が存することを見出し、本発明の完
成に至った。<Means for Solving the Problems> Therefore, the present inventor has solved these problems in the above-mentioned conventional methods, has a safe and excellent water retention ability, and activates skin cells to give a beautiful skin effect. As a result of intensive research to find a substance, the present inventors have found that the above-mentioned effect is present in a specific complex protein contained in the parotid gland of cattle, and completed the present invention.
すなわち、本発明は牛の耳下腺からpH7〜9の弱アルカ
リ性下で水抽出した後、抽出液のpHを5.4に調整するこ
とにより沈澱物として得られた複合蛋白質を0.001〜1
重量%含有することを特徴とする化粧料に関するもので
ある。That is, according to the present invention, 0.001 to 1 of the complex protein obtained as a precipitate was obtained by extracting water from the parotid gland of cattle with water under a weak alkaline condition of pH 7 to 9 and then adjusting the pH of the extract to 5.4.
The present invention relates to a cosmetic material characterized by being contained in a weight percentage.
本発明に適用される複合蛋白質とは、牛の耳下腺から水
系抽出された後、必要に応じて濃縮、更には抽出液のpH
を5.4に調整して沈澱物として得られるものであり、こ
の中には分子量数十万の各種の複合蛋白質が豊富に含ま
れたものとなっている。The complex protein applied to the present invention is water-based extraction from the parotid gland of cattle, then concentrated if necessary, and further the pH of the extract.
It was obtained as a precipitate by adjusting to 5.4, which contains abundant various complex proteins with a molecular weight of several hundred thousand.
斯る上記の如き複合蛋白質については、既に多くの知見
が得られている。例えば、牛の耳下腺から水抽出・分離
された抽出物は、分子量約13万の複合蛋白質であり、ま
た牛の顎下腺からも同一の物質が得られている。また、
特開昭53−104714号公報には、牛の耳下腺の水抽出液を
pH5.4に調整することによって生ずる沈澱を除去した残
液にアセトンを加えて分離して得られる抽出物も分子量
約66,000の複合蛋白質であると報告されている。一方、
人の唾液から得られる抽出物(分子量約15,900)(Y.It
o.J.Biochem.1960,475)や複合蛋白質E−3(分子量約
55,000)(薬学雑誌89.482,1969)100−1画分(分子量
約350,000)(薬学雑誌92(7)796−800,1972)などが
報告されている。更に、特開昭52−72887号には、唾液
腺抽出物に蛋白分解酵素を作用させて得られる新規なペ
プチド(活性ペプチドH−1、分子量740及びAA−1、
分子量9,000)も報告されている。Many findings have already been obtained for such complex proteins as described above. For example, an extract extracted from water of the parotid gland of a cow is a complex protein having a molecular weight of about 130,000, and the same substance is obtained from the submandibular gland of a cow. Also,
JP-A-53-104714 discloses an aqueous extract of the parotid gland of a cow.
It has been reported that the extract obtained by adding acetone to the residual liquid from which the precipitate generated by adjusting the pH to 5.4 is removed and separating it is a complex protein having a molecular weight of about 66,000. on the other hand,
Extract from human saliva (molecular weight about 15,900) (Y.It
oJBiochem.1960,475) and complex protein E-3 (molecular weight approx.
55,000) (pharmaceutical journal 89.482,1969) 100-1 fraction (molecular weight about 350,000) (pharmaceutical journal 92 (7) 796-800,1972) and the like have been reported. Further, Japanese Patent Laid-Open No. 52-72887 discloses a novel peptide (active peptide H-1, molecular weight 740 and AA-1, obtained by reacting a salivary gland extract with a protease.
A molecular weight of 9,000) has also been reported.
これらの唾液腺あるいは唾液から抽出して得られる複合
蛋白質群は、これまでに筋肉内注射や経口投与すること
によって血清カルシウムの低下作用、循環白血球数上昇
作用、血清クエン酸低下作用、血清酸性フォスファター
ゼ低下作用、免疫能力増進作用(例、抗ガン作用)、ヒ
スタミンストレス(中枢系)発現の促進作用、更にはテ
ストステロン生合成の促進作用などの生理的作用が知ら
れていたが、外用的な作用については殆んど研究された
ことがなく、言わんや本発明の化粧料におけるが如き、
皮膚に対する保水機能や美肌効果を有することについて
は全く知らてれいなかった。The complex proteins obtained from these salivary glands or saliva have been previously administered intramuscularly or orally to reduce serum calcium, increase circulating white blood cell count, decrease serum citrate, and decrease serum acid phosphatase. It has been known to have physiological actions such as action, immune function enhancing action (eg, anti-cancer action), promoting histamine stress (central system) expression, and further promoting testosterone biosynthesis. Has hardly been studied, as it is in the cosmetic of the present invention,
Nothing was known about having a water-retaining function or a skin-beautifying effect on the skin.
次に、本発明に適用される複合蛋白質の製造法について
説明する。牛の耳下腺からの複合蛋白質の抽出はそれ自
体公知の方法により行なうことができる。すなわち、牛
の耳下腺から採取した新鮮な腺体を細断したものに、pH
7〜9好ましくはpH8に調整した弱アルカリ性の水を加
え、撹拌しながら抽出を行なう。撹拌は一般に冷却下、
数時間行なわれる。抽出が終了したら、混合液をロ過
し、水性抽出液を分離する。得られた水性抽出液に無機
酸例えば塩酸を加えてpHを5.4に調整し得られた沈澱を
遠心分離法などにより分離・乾燥したものを用いたり、
更には遠心分離により回収した上澄液をpH5.4に調整し
た後、これにアセトンを加えて沈澱を生ぜしめ、分離・
乾燥したものを用いる。Next, the method for producing the complex protein applied to the present invention will be described. Extraction of the complex protein from the parotid gland of bovine can be performed by a method known per se. In other words, the fresh glandular body collected from the parotid gland of a cow was chopped into
7-9 Preferably weakly alkaline water adjusted to pH 8 is added and extraction is carried out with stirring. Stirring is generally under cooling,
It will take several hours. When the extraction is complete, the mixture is filtered and the aqueous extract is separated. An inorganic acid such as hydrochloric acid may be added to the obtained aqueous extract to adjust the pH to 5.4, and the obtained precipitate may be separated and dried by a centrifugation method or the like, or
Furthermore, after adjusting the pH of the supernatant recovered by centrifugation to 5.4, acetone was added to this to cause precipitation and separation.
Use the dried one.
斯様にして得られた牛の耳下腺からの複合蛋白質は、皮
膚に対し大きな効果を発現する高分子量複合蛋白質を主
要成分とし、その他糖類、脂質類などを含んだものとな
っている。The thus obtained bovine parotid gland complex protein contains a high-molecular-weight complex protein that exerts a great effect on the skin as a main component, and also contains saccharides, lipids and the like.
次に、本発明の化粧料における複合蛋白質の含有量は、
化粧料全量中の0.001重量%以上が選択される。これよ
り少ない量では、保水性、美肌効果の作用が弱く本発明
の目的を達し得ない。一方、含有量の上限については特
に制約はないが、含有量の増加を行なっても効果の頭打
ち現象が見られ増量効果がなく経済的ではないこと、及
び化粧料剤型に対して複合蛋白質の種類によっては溶解
(配合)限界があることなどから、通常は0.01〜1重量
%の範囲に留まるものである。Next, the content of the complex protein in the cosmetic of the present invention is
0.001% by weight or more of the total amount of cosmetics is selected. If the amount is less than the above range, the effects of water retention and skin beautifying effect are weak and the object of the present invention cannot be achieved. On the other hand, there is no particular restriction on the upper limit of the content, but even if the content is increased, a phenomenon of reaching the ceiling of the effect is seen and there is no effect of increasing the amount, and it is not economical, Depending on the type, there is a limit of dissolution (blending), etc., so that the content is usually 0.01 to 1% by weight.
また、本発明の化粧料では上記複合蛋白質に加えて、通
常化粧料において用いられる油分、界面活性剤、多価ア
ルコール類を含む保湿剤、酸化安定剤、顔料、紫外線吸
収剤、防腐剤、香料などを、上記複合蛋白質中の蛋白が
変質しない範囲で配合することができる。そして、この
ようにして提供される本発明の化粧料としては、ローシ
ョン、ミルク、クリーム類などのほか、アンダーメー
ク、ファンデーション等幅広いものが挙げられる。ま
た、化粧料の製造方法自体は特に制約はなく、例えば上
記複合蛋白質を水相成分の一つとして他の成分と共に配
合して調整される。Further, in the cosmetic of the present invention, in addition to the above complex protein, oils, surfactants, moisturizers containing polyhydric alcohols, oxidation stabilizers, pigments, ultraviolet absorbers, preservatives, and fragrances which are usually used in cosmetics. And the like can be blended in such a range that the protein in the complex protein does not deteriorate. The cosmetics of the present invention thus provided include, in addition to lotions, milks, creams, a wide range of undermakes, foundations and the like. The method for producing cosmetics is not particularly limited, and may be prepared, for example, by blending the above-mentioned complex protein as one of the aqueous phase components together with other components.
ここで、本発明をさらに詳細に説明するため、本発明に
係る複合蛋白質の製造例を示す。Here, in order to explain the present invention in more detail, an example of producing the composite protein according to the present invention will be shown.
製造例1、 細断した牛耳下腺500gに水1を加え、水酸化ナトリウ
ム溶液を添加してpHを8.0に調整した。これを5℃下で
5時間撹拌した後、ロ過してロ液を採取した。残渣に再
び1の水を加え、pHを8.0に調整した後、5℃下で2
時間撹拌し、その後ロ過してロ液を採取し、これを先の
ロ液と一緒にした。Production Example 1 To 500 g of shredded parotid gland was added water 1 and a sodium hydroxide solution was added to adjust the pH to 8.0. This was stirred at 5 ° C. for 5 hours and then filtered to collect a filtrate. Water was added to the residue 1 again to adjust the pH to 8.0, and then 2 at 5 ° C.
The mixture was stirred for a period of time and then filtered to collect a filtrate, which was combined with the previous filtrate.
次に、このロ液に0.1N塩酸を加えpH5.4に調整し、一晩
冷蔵庫中に放置後4,000rpmで10分間遠心分離を行ない沈
澱物を採取した。上澄液は1まで減圧濃縮した後、再
びpHを5.4に調整し、一晩冷蔵庫に放置後、遠心分離を
行なって沈澱物を採取した。得られた沈澱物を併せた
後、脱水乾燥して複合蛋白質2.2gを得た。Next, 0.1N hydrochloric acid was added to this filtrate to adjust the pH to 5.4, and the mixture was left in a refrigerator overnight and then centrifuged at 4,000 rpm for 10 minutes to collect a precipitate. The supernatant was concentrated under reduced pressure to 1, the pH was adjusted to 5.4 again, and the mixture was left overnight in the refrigerator and then centrifuged to collect the precipitate. The obtained precipitates were combined and then dehydrated and dried to obtain 2.2 g of a complex protein.
製造例2、 製造例1で沈澱物を除去して得られた上澄液を再度0.1N
塩酸でpH5.4に調整し、これにアセトン1を加えて、
一晩冷蔵庫に放置した。生じた沈澱を4,000rpmで10分間
遠心分離して採取し、脱水乾燥して複合蛋白質14gを得
た。Preparative Example 2 The supernatant obtained by removing the precipitate in Preparative Example 1 was reused with 0.1N.
Adjust the pH to 5.4 with hydrochloric acid, add acetone 1 to this,
I left it in the refrigerator overnight. The resulting precipitate was collected by centrifugation at 4,000 rpm for 10 minutes, dehydrated and dried to obtain 14 g of a complex protein.
本発明では、以上の如くして得られた複合蛋白質を配合
することにより、該複合蛋白質の有する保水能を利用し
て皮膚水和効果を高めてみずみずしい肌を与えるととも
に、加齢に伴なう皮膚細胞の老化に対して作用し、皮膚
の老化を予防し得る効果が期待される。In the present invention, by blending the complex protein obtained as described above, the water hydration effect of the complex protein is utilized to enhance the skin hydration effect to give a fresh skin, and to accompany aging. It is expected to have an effect of acting on the aging of skin cells and preventing the aging of the skin.
そこで本発明者は、後記実施例1に示した本発明の複合
蛋白質を配合したクリームを製造し、実使用テストを行
なって、その老化予防に対する効力を確認した。尚、比
較品としては後記実施例1に示したクリームより本発明
の複合蛋白質を除いて製造したクリーム(水を増量)を
用いた。試験方法については下記に示し、その結果を表
−1に示す。Therefore, the present inventor manufactured a cream containing the complex protein of the present invention shown in Example 1 described later, and conducted a practical use test to confirm its efficacy in preventing aging. As a comparative product, a cream prepared by removing the complex protein of the present invention from the cream shown in Example 1 (to increase the amount of water) was used. The test methods are shown below, and the results are shown in Table-1.
<方法> 老人性乾皮症を呈する被験者12名を抽出し、
それぞれ無作為にA群(6名)、B群(6名)に分け、
A群には本発明のクリームを、B群には比較品のクリー
ムを、1日3回(朝、昼、晩)3ヶ月間使用してもら
い、3ヶ月後の肌の状態を確認した。<Method> Twelve subjects with senile xerosis are extracted,
Randomly divided into A group (6 people) and B group (6 people),
The group A was made to use the cream of the present invention and the group B was made to use the cream of the comparative product three times a day (morning, noon and evening) for 3 months, and the skin condition after 3 months was confirmed.
同様に、本発明者らは、後記実施例3の化粧水を用い
て、以下に示す方法で保水効果に対する効果の確認を行
なった。その結果を表−2に示す。 Similarly, the present inventors confirmed the effect on the water retention effect by the following method using the lotion of Example 3 described later. The results are shown in Table-2.
<方法> 乾燥肌を有する女性60名を抽出し、それぞれ
30名ずつ無作為にA群、B群に分け、A群には本発明の
化粧水を、B群には比較品の化粧水(複合蛋白質無配
合)を、1日3回(朝、昼、晩)及び随時に1ヶ月連用
してもらい、使用感、使用後の肌の状態及び1ヶ月後の
表皮形態の観察を行なった。<Method> 60 women with dry skin were extracted and
30 people were randomly divided into groups A and B, and the lotion of the present invention was added to group A, and the lotion of comparative product (without complex protein) was added to group B three times a day (morning, noon). , Night) and as needed for 1 month, and observed the feeling of use, the condition of the skin after use, and the morphology of the epidermis after 1 month.
表−1、表−2の結果から明からな如く、本発明の複合
蛋白質を配合した化粧料は、肌の保水性を向上させしっ
とり感を付与し、また皮膚の老化に対する改善作用を有
し美肌効果を与える優れたものとなっている。また、何
れの連用テストでも被験者の肌の状態に異常は認められ
ず、安全性上も問題のないことが確認された。 As is clear from the results of Tables 1 and 2, the cosmetic containing the complex protein of the present invention improves the water retention of the skin, imparts a moist feeling, and has the effect of improving the aging of the skin. It is an excellent product that gives a beautiful skin effect. Further, no abnormality was found in the skin condition of the subject in any of the continuous tests, and it was confirmed that there was no problem in safety.
尚、この複合蛋白質に由来する美肌効果については、複
合蛋白質の生理活性にもとずく細胞賦活効果が中心であ
るのか、高分子量蛋白質に起因する保水性が主であるの
かは明らかになっていないが、これらの相乗効果による
ものと推定される。In addition, regarding the skin beautifying effect derived from this complex protein, it has not been clarified whether the cell activation effect based on the physiological activity of the complex protein is the main, or whether the water retention due to the high molecular weight protein is the main one. Is presumed to be due to these synergistic effects.
<実施例> 以下に実施例を示す。尚、配合割合は重量%である。<Examples> Examples are shown below. The mixing ratio is% by weight.
実施例1、クリーム (A)セタノール 5.0 ミツロウ 5.0 マイクロクリスタリンワックス 5.0 ワセリン 5.0 スクワラン 10.0 グリセリンモノステアレート 2.0 P.E.O(20)ソルビタンモノステアレート 2.0 (B)1,3−ブチレングリコール 5.0 グリセリン 4.0 エチルパラベン 0.1 複合蛋白質(製造例1) 0.1 精製水 56.8 (方法) (A)及び(B)を個別に80℃に加熱して溶解し、両者
を混合を混合して乳化する。次に30℃まで冷却してクリ
ームとする。Example 1, Cream (A) Cetanol 5.0 Beeswax 5.0 Microcrystalline Wax 5.0 Vaseline 5.0 Squalane 10.0 Glycerin Monostearate 2.0 PEO (20) Sorbitan Monostearate 2.0 (B) 1,3-Butylene Glycol 5.0 Glycerin 4.0 Ethylparaben 0.1 Complex Protein (Production Example 1) 0.1 Purified water 56.8 (Method) (A) and (B) are individually heated to 80 ° C. to dissolve them, and both are mixed and emulsified. Then cool to 30 ° C to make a cream.
実施例2、乳 液 (A)セタノール 1.0 ワセリン 2.0 ミツロウ 2.0 スクワラン 10.0 P.E.O(20)ソルビタンモノステアレート 3.0 ソルビタンモノステアレート 1.5 (B)カルボキシルビニルポリマー(1%aq) 15.0 水酸化カリウム 0.05 1,3−ブチレングリコール 8.0 メチルパラベン 0.1 ローヤルゼリー(生) 0.1 複合蛋白質(製造例2) 0.05 精製水 57.2 (方法) 実施例1と同様にして乳液を得た。Example 2, Emulsion (A) Cetanol 1.0 Vaseline 2.0 Beeswax 2.0 Squalane 10.0 PEO (20) Sorbitan monostearate 3.0 Sorbitan monostearate 1.5 (B) Carboxyl vinyl polymer (1% aq) 15.0 Potassium hydroxide 0.05 1,3 -Butylene glycol 8.0 Methylparaben 0.1 Royal jelly (raw) 0.1 Complex protein (Production Example 2) 0.05 Purified water 57.2 (Method) An emulsion was obtained in the same manner as in Example 1.
実施例3、化粧水 エタノール 7.0 1,3−ブチレングリコール 3.0 グリセリン 2.0 P.O.E(40)硬化ヒマシ油 0.5 クエン酸 0.01 クエン酸ソーダ 0.1 メチルパラベン 0.05 複合蛋白質(製造例1) 0.01 香 料 0.1 精製水 87.23 (方法) 室温下、混合して化粧水を得た。Example 3, lotion lotion Ethanol 7.0 1,3-butylene glycol 3.0 glycerin 2.0 POE (40) hydrogenated castor oil 0.5 citric acid 0.01 sodium citrate 0.1 methylparaben 0.05 complex protein (Production Example 1) 0.01 fragrance 0.1 purified water 87.23 (method ) The mixture was mixed at room temperature to obtain a lotion.
実施例4、ファンデーション (A)ステアリン酸 5.0 グリセリンモノステアレート 2.5 セタノール 1.0 スクワラン 3.0 流動パラフィン 7.0 ミリスチン酸イソプロピル 8.0 (B)1,3−ブチレングリコール 3.0 トリエタノールアミン 1.2 メチルパラベン 0.2 複合蛋白質(製造例2) 0.001 精製水 52.119 (C)酸化チタン 8.0 カオリン 5.0 タルク 2.0 ベントナイト 1.0 ベンガラ 0.16 黄酸化鉄 0.5 黒酸化鉄 0.02 (D)香料 0.3 (方法) (C)を混合し粉砕する。(B)を混合溶解し、これに
(C)を加え分散させた後75℃に加熱する。(A)を80
℃に加熱し、これを(B)に加えて乳化した。その後、
45℃まで冷却し、(D)を加えた後、30℃まで冷却して
クリーム状のファンデーションを得た。Example 4, Foundation (A) Stearic Acid 5.0 Glycerin Monostearate 2.5 Cetanol 1.0 Squalane 3.0 Liquid Paraffin 7.0 Isopropyl myristate 8.0 (B) 1,3-Butylene Glycol 3.0 Triethanolamine 1.2 Methylparaben 0.2 Complex Protein (Production Example 2) 0.001 Purified water 52.119 (C) Titanium oxide 8.0 Kaolin 5.0 Talc 2.0 Bentonite 1.0 Bengala 0.16 Yellow iron oxide 0.5 Black iron oxide 0.02 (D) Perfume 0.3 (Method) (C) is mixed and ground. (B) is mixed and dissolved, (C) is added and dispersed therein, and then heated to 75 ° C. (A) 80
The mixture was heated to ℃, added to (B) and emulsified. afterwards,
After cooling to 45 ° C and adding (D), the mixture was cooled to 30 ° C to obtain a creamy foundation.
───────────────────────────────────────────────────── フロントページの続き (56)参考文献 特開 昭50−160413(JP,A) 特開 昭59−98727(JP,A) 特開 昭61−5006(JP,A) 特開 昭61−210013(JP,A) ─────────────────────────────────────────────────── ─── Continuation of the front page (56) References JP-A-50-160413 (JP, A) JP-A-59-98727 (JP, A) JP-A-61-5006 (JP, A) JP-A-61- 210013 (JP, A)
Claims (1)
で水抽出した後、抽出液のpHを5.4に調整することによ
り沈澱物として得られた複合蛋白質を0.001〜1重量%
含有することを特徴とする化粧料。1. A composite protein obtained as a precipitate by water-extracting from the parotid gland of a bovine under mild alkaline condition of pH 7 to 9 and then adjusting the pH of the extract to 5.4 to 0.001 to 1% by weight.
Cosmetics characterized by containing.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60-122335 | 1985-06-05 | ||
| JP12233585 | 1985-06-05 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6289610A JPS6289610A (en) | 1987-04-24 |
| JPH0755896B2 true JPH0755896B2 (en) | 1995-06-14 |
Family
ID=14833420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP61013721A Expired - Lifetime JPH0755896B2 (en) | 1985-06-05 | 1986-01-27 | Cosmetics |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0755896B2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4424759B2 (en) * | 1997-04-28 | 2010-03-03 | あすか製薬株式会社 | Moisturizer, cosmetics and pharmaceuticals containing it |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR207237A1 (en) * | 1974-02-25 | 1976-09-22 | Thomas A | PROCEDURE FOR OBTAINING SOLUBLE LYOPHILIZED STABLE BIOLOGICAL EXTRACTS CONSTITUTED BY THERMORE RESISTANT PROTEIN COMPLEXES |
| JPS5998727A (en) * | 1982-11-26 | 1984-06-07 | Shiseido Co Ltd | Emulsified composition |
| JPS615006A (en) * | 1984-06-19 | 1986-01-10 | Sanki Shoji Kk | Agent for skin |
| JPH0645524B2 (en) * | 1985-03-13 | 1994-06-15 | 岩瀬コスファ株式会社 | External skin preparation |
-
1986
- 1986-01-27 JP JP61013721A patent/JPH0755896B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6289610A (en) | 1987-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1322532C (en) | Trehalose containing cosmetic composition and method of using it | |
| JPWO2002007745A1 (en) | Antipruritic composition and wound healing promoting composition | |
| JP3135943B2 (en) | Whitening agent | |
| JP2001081008A (en) | Skin preparation for external use keeping and improving the skin from chapping | |
| JP2002003358A (en) | Skin care preparation | |
| JP3513872B2 (en) | External preparation for skin | |
| JPH0611686B2 (en) | Cosmetics | |
| JP3280903B2 (en) | External preparation for skin | |
| JP3172753B2 (en) | Biological hyaluronic acid synthesis promoter | |
| JP2004099503A (en) | Hgf production promoter and cosmetic containing the same | |
| KR102247589B1 (en) | Cosmetic composition for improving skin comprising the moluccella laevis extraction and the hololeion maximowiczii Kitam. extraction as an effective ingredient | |
| JP3199277B2 (en) | Cosmetics | |
| JP3278138B2 (en) | External preparation for skin | |
| JP2001288068A (en) | Skin cosmetics | |
| JP3342050B2 (en) | Cosmetics | |
| JPH0755896B2 (en) | Cosmetics | |
| JP2003192567A (en) | Cosmetic | |
| JP3105664B2 (en) | External preparation for skin | |
| JP3044690B2 (en) | Cosmetics | |
| KR100525722B1 (en) | Topical constituents of ginsenoside Rh2 and ginsenoside Rg3 | |
| JPH11279072A (en) | External preparation for skin | |
| JP4054698B2 (en) | Cosmetics containing an extract from squid follicular gland and method for collecting extract from squid follicular gland | |
| JPH0665039A (en) | Cosmetics | |
| JP2000226321A (en) | Skin-conditioning cosmetic | |
| JP2011231055A (en) | Cosmetic for skin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EXPY | Cancellation because of completion of term |